ID GTR7_HUMAN Reviewed; 512 AA. AC Q6PXP3; A2A333; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2007, sequence version 2. DT 02-SEP-2026, entry version 163. DE RecName: Full=Solute carrier family 2, facilitated glucose transporter member 7 {ECO:0000305}; DE AltName: Full=Glucose transporter type 7 {ECO:0000303|PubMed:15033637}; DE Short=GLUT-7 {ECO:0000303|PubMed:15033637}; DE Short=hGLUT7 {ECO:0000303|PubMed:16186102}; GN Name=SLC2A7 {ECO:0000303|PubMed:15033637, GN ECO:0000312|HGNC:HGNC:13445}; GN Synonyms=GLUT7 {ECO:0000303|PubMed:15033637}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND RP TISSUE SPECIFICITY. RX PubMed=15033637; DOI=10.1152/ajpgi.00396.2003; RA Li Q., Manolescu A.R., Ritzel M., Yao S., Slugoski M., Young J.D., RA Chen X.-Z., Cheeseman C.I.; RT "Cloning and functional characterization of the human GLUT7 isoform SLC2A7 RT from the small intestine."; RL Am. J. Physiol. 287:G236-G242(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ILE-302. RX PubMed=16186102; DOI=10.1074/jbc.m508678200; RA Manolescu A., Salas-Burgos A.M., Fischbarg J., Cheeseman C.I.; RT "Identification of a hydrophobic residue as a key determinant of fructose RT transport by the facilitative hexose transporter SLC2A7 (GLUT7)."; RL J. Biol. Chem. 280:42978-42983(2005). RN [5] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=28083649; DOI=10.1007/s00232-016-9945-7; RA Ebert K., Ludwig M., Geillinger K.E., Schoberth G.C., Essenwanger J., RA Stolz J., Daniel H., Witt H.; RT "Reassessment of GLUT7 and GLUT9 as putative fructose and glucose RT transporters."; RL J. Membr. Biol. 250:171-182(2017). RN [6] RP SUBCELLULAR LOCATION, FUNCTION, ACTIVITY REGULATION, AND INDUCTION BY RP FRUCTOSE. RX PubMed=29548810; DOI=10.1016/j.bcp.2018.03.011; RA Gauer J.S., Tumova S., Lippiat J.D., Kerimi A., Williamson G.; RT "Differential patterns of inhibition of the sugar transporters GLUT2, GLUT5 RT and GLUT7 by flavonoids."; RL Biochem. Pharmacol. 152:11-20(2018). CC -!- FUNCTION: Probable sugar transporter (PubMed:28083649). Even if its CC physiological substrate is subject to discussion, it is able to CC transport glucose and fructose (PubMed:16186102, PubMed:28083649, CC PubMed:29548810). Does not transport galactose, 2-deoxy-d-glucose and CC xylose (PubMed:15033637). {ECO:0000269|PubMed:15033637, CC ECO:0000269|PubMed:16186102, ECO:0000269|PubMed:28083649, CC ECO:0000269|PubMed:29548810}. CC -!- CATALYTIC ACTIVITY: CC Reaction=D-glucose(out) = D-glucose(in); Xref=Rhea:RHEA:60376, CC ChEBI:CHEBI:4167; Evidence={ECO:0000269|PubMed:16186102, CC ECO:0000269|PubMed:29548810}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-fructose(out) = D-fructose(in); Xref=Rhea:RHEA:60372, CC ChEBI:CHEBI:37721; Evidence={ECO:0000269|PubMed:16186102, CC ECO:0000269|PubMed:29548810}; CC -!- ACTIVITY REGULATION: Glucose and fructose transport are inhibited by CC the flavonoid apigenin. {ECO:0000269|PubMed:29548810}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=300 uM for glucose {ECO:0000269|PubMed:15033637}; CC -!- INTERACTION: CC Q6PXP3; Q02410: APBA1; NbExp=2; IntAct=EBI-54689289, EBI-368690; CC Q6PXP3; Q99767: APBA2; NbExp=2; IntAct=EBI-54689289, EBI-81711; CC Q6PXP3; Q12959: DLG1; NbExp=3; IntAct=EBI-54689289, EBI-357481; CC Q6PXP3; Q92796: DLG3; NbExp=3; IntAct=EBI-54689289, EBI-80440; CC Q6PXP3; P78352: DLG4; NbExp=3; IntAct=EBI-54689289, EBI-80389; CC Q6PXP3; Q68DX3: FRMPD2; NbExp=3; IntAct=EBI-54689289, EBI-53993476; CC Q6PXP3; A4D2P6: GRID2IP; NbExp=2; IntAct=EBI-54689289, EBI-15893226; CC Q6PXP3; Q9Y3R0: GRIP1; NbExp=5; IntAct=EBI-54689289, EBI-5349621; CC Q6PXP3; Q9C0E4: GRIP2; NbExp=5; IntAct=EBI-54689289, EBI-949557; CC Q6PXP3; Q14005: IL16; NbExp=3; IntAct=EBI-54689289, EBI-2831580; CC Q6PXP3; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-54689289, EBI-739832; CC Q6PXP3; Q8N448: LNX2; NbExp=2; IntAct=EBI-54689289, EBI-2340947; CC Q6PXP3; Q96QZ7: MAGI1; NbExp=2; IntAct=EBI-54689289, EBI-924464; CC Q6PXP3; Q86UL8: MAGI2; NbExp=4; IntAct=EBI-54689289, EBI-311035; CC Q6PXP3; O75970: MPDZ; NbExp=3; IntAct=EBI-54689289, EBI-821405; CC Q6PXP3; Q86UT5: NHERF4; NbExp=2; IntAct=EBI-54689289, EBI-8744528; CC Q6PXP3; Q8NI35: PATJ; NbExp=9; IntAct=EBI-54689289, EBI-724390; CC Q6PXP3; Q5T2W1: PDZK1; NbExp=3; IntAct=EBI-54689289, EBI-349819; CC Q6PXP3; Q14160: SCRIB; NbExp=3; IntAct=EBI-54689289, EBI-357345; CC Q6PXP3; Q07157: TJP1; NbExp=2; IntAct=EBI-54689289, EBI-79553; CC Q6PXP3; Q9P202: WHRN; NbExp=2; IntAct=EBI-54689289, EBI-310886; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16186102, CC ECO:0000269|PubMed:28083649}; Multi-pass membrane protein CC {ECO:0000255}. Apical cell membrane {ECO:0000269|PubMed:29548810}; CC Multi-pass membrane protein {ECO:0000255}. CC -!- TISSUE SPECIFICITY: Expressed in small intestine and colon CC (PubMed:15033637). Weakly expressed in testis and prostate CC (PubMed:15033637). {ECO:0000269|PubMed:15033637}. CC -!- INDUCTION: Expression is increased in presence of fructose. CC {ECO:0000269|PubMed:29548810}. CC -!- SIMILARITY: Belongs to the major facilitator superfamily. Sugar CC transporter (TC 2.A.1.1) family. Glucose transporter subfamily. CC {ECO:0000305}. CC -!- CAUTION: According to some reports, mediates transmembrane transport of CC glucose and fructose (PubMed:15033637, PubMed:16186102, CC PubMed:29548810). However, another group could not confirm transporter CC activity for glucose or fructose (PubMed:28083649). CC {ECO:0000269|PubMed:15033637, ECO:0000269|PubMed:16186102, CC ECO:0000269|PubMed:28083649, ECO:0000269|PubMed:29548810}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY571960; AAS78590.2; -; mRNA. DR EMBL; AL158048; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471130; EAW71607.1; -; Genomic_DNA. DR CCDS; CCDS98.2; -. DR RefSeq; NP_997303.2; NM_207420.3. DR PDB; 9J2N; EM; 3.30 A; A=1-512. DR AlphaFoldDB; Q6PXP3; -. DR EMDB; EMD-61099; -. DR SMR; Q6PXP3; -. DR BioGRID; 127578; 106. DR FunCoup; Q6PXP3; 61. DR IntAct; Q6PXP3; 171. DR NDEx; IQUERY-CP-SLC2A7; 2 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000383698; -. DR DrugBank; DB01914; D-glucose. DR DrugBank; DB09341; Dextrose, unspecified form. DR DrugBank; DB09502; Fludeoxyglucose (18F). DR TCDB; 2.A.1.1.37; the major facilitator superfamily (mfs). DR GlyCosmos; Q6PXP3; 1 site, No reported glycans. DR GlyGen; Q6PXP3; 2 sites. DR iPTMnet; Q6PXP3; -. DR BioMuta; SLC2A7; -. DR DMDM; 167008866; -. DR jPOST; Q6PXP3; -. DR MassIVE; Q6PXP3; -. DR PaxDb; 9606-ENSP00000383698; -. DR PeptideAtlas; Q6PXP3; -. DR ProteomicsDB; 67261; -. DR Antibodypedia; 49274; 16 antibodies from 8 providers. DR DNASU; 155184; -. DR Ensembl; ENST00000400906.2; ENSP00000383698.1; ENSG00000197241.4. DR GeneID; 155184; -. DR KEGG; hsa:155184; -. DR MANE-Select; ENST00000400906.2; ENSP00000383698.1; NM_207420.3; NP_997303.2. DR UCSC; uc009vmo.1; human. DR AGR; HGNC:13445; -. DR ClinPGx; PA37770; -. DR CTD; 155184; -. DR DisGeNET; 155184; -. DR GeneCards; SLC2A7; -. DR HGNC; HGNC:13445; SLC2A7. DR HPA; ENSG00000197241; Tissue enriched (intestine). DR MIM; 610371; gene. DR VEuPathDB; HostDB:ENSG00000197241; -. DR eggNOG; KOG0569; Eukaryota. DR GeneTree; ENSGT00940000162742; -. DR HOGENOM; CLU_001265_30_11_1; -. DR InParanoid; Q6PXP3; -. DR OMA; TEVFVII; -. DR OrthoDB; 4540492at2759; -. DR PAN-GO; Q6PXP3; 4 GO annotations based on evolutionary models. DR PhylomeDB; Q6PXP3; -. DR PathwayCommons; Q6PXP3; -. DR Reactome; R-HSA-189200; Cellular hexose transport. DR BioGRID-ORCS; 155184; 11 hits in 1137 CRISPR screens. DR ChiTaRS; SLC2A7; human. DR GeneWiki; SLC2A7; -. DR GenomeRNAi; 155184; -. DR Pharos; Q6PXP3; Tdark. DR PRO; PR:Q6PXP3; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q6PXP3; protein. DR Bgee; ENSG00000197241; Expressed in duodenum and 3 other cell types or tissues. DR GO; GO:0016324; C:apical plasma membrane; EXP:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0055056; F:D-glucose transmembrane transporter activity; IDA:UniProtKB. DR GO; GO:0005353; F:fructose transmembrane transporter activity; IDA:UniProtKB. DR GO; GO:0051119; F:sugar transmembrane transporter activity; TAS:Reactome. DR GO; GO:1904659; P:D-glucose transmembrane transport; IDA:UniProtKB. DR GO; GO:0070837; P:dehydroascorbic acid transport; IBA:GO_Central. DR GO; GO:0015755; P:fructose transmembrane transport; IDA:UniProtKB. DR GO; GO:0008645; P:hexose transmembrane transport; TAS:Reactome. DR CDD; cd17432; MFS_GLUT_Class2; 1. DR FunFam; 1.20.1250.20:FF:000029; solute carrier family 2, facilitated glucose transporter member 4; 1. DR Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1. DR InterPro; IPR045263; GLUT. DR InterPro; IPR020846; MFS_dom. DR InterPro; IPR005828; MFS_sugar_transport-like. DR InterPro; IPR036259; MFS_trans_sf. DR InterPro; IPR003663; Sugar/inositol_transpt. DR InterPro; IPR005829; Sugar_transporter_CS. DR NCBIfam; TIGR00879; SP; 1. DR PANTHER; PTHR23503; SOLUTE CARRIER FAMILY 2; 1. DR PANTHER; PTHR23503:SF30; SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 7; 1. DR Pfam; PF00083; Sugar_tr; 1. DR PRINTS; PR00171; SUGRTRNSPORT. DR SUPFAM; SSF103473; MFS general substrate transporter; 1. DR PROSITE; PS50850; MFS; 1. DR PROSITE; PS00216; SUGAR_TRANSPORT_1; 1. DR PROSITE; PS00217; SUGAR_TRANSPORT_2; 1. DR PDBsum; 9J2N; -. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Glycoprotein; Membrane; KW Proteomics identification; Reference proteome; Sugar transport; KW Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..512 FT /note="Solute carrier family 2, facilitated glucose FT transporter member 7" FT /id="PRO_0000317274" FT TOPO_DOM 1..21 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 22..42 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 43..78 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 79..99 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 100..107 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 108..128 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 129..138 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 139..159 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 160..172 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 173..193 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 194..198 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 199..219 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 220..281 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 282..302 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 303..321 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 322..342 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 343..350 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 351..371 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 372..379 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 380..400 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 401..415 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 416..436 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 437..445 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 446..466 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 467..512 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 491..512 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 294..295 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /evidence="ECO:0000250|UniProtKB:P11169" FT BINDING 300 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /evidence="ECO:0000250|UniProtKB:P11169" FT BINDING 331 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /evidence="ECO:0000250|UniProtKB:P11169" FT CARBOHYD 57 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VARIANT 135 FT /note="V -> I (in dbSNP:rs34545462)" FT /id="VAR_052504" FT VARIANT 261 FT /note="R -> Q (in dbSNP:rs12402973)" FT /id="VAR_061879" FT MUTAGEN 302 FT /note="I->S: Does not affect glucose or fructose FT transport." FT /evidence="ECO:0000269|PubMed:16186102" FT MUTAGEN 302 FT /note="I->V: Abolished fructose transport." FT /evidence="ECO:0000269|PubMed:16186102" FT HELIX 21..42 FT /evidence="ECO:0007829|PDB:9J2N" FT STRAND 43..46 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 49..64 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 70..92 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 95..111 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 113..123 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 124..129 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 132..159 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 162..164 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 165..186 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 189..192 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 195..197 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 198..203 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 204..206 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 207..215 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 216..218 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 220..222 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 225..230 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 233..243 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 250..266 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 272..276 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 278..280 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 281..295 FT /evidence="ECO:0007829|PDB:9J2N" FT STRAND 296..298 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 299..312 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 320..345 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 347..370 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 371..374 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 376..378 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 379..395 FT /evidence="ECO:0007829|PDB:9J2N" FT TURN 396..398 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 399..407 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 414..433 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 436..443 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 447..464 FT /evidence="ECO:0007829|PDB:9J2N" FT HELIX 474..484 FT /evidence="ECO:0007829|PDB:9J2N" SQ SEQUENCE 512 AA; 55728 MW; DCA09E35AB720382 CRC64; MENKEAGTPP PIPSREGRLQ PTLLLATLSA AFGSAFQYGY NLSVVNTPHK VFKSFYNETY FERHATFMDG KLMLLLWSCT VSMFPLGGLL GSLLVGLLVD SCGRKGTLLI NNIFAIIPAI LMGVSKVAKA FELIVFSRVV LGVCAGISYS ALPMYLGELA PKNLRGMVGT MTEVFVIVGV FLAQIFSLQA ILGNPAGWPV LLALTGVPAL LQLLTLPFFP ESPRYSLIQK GDEATARQAL RRLRGHTDME AELEDMRAEA RAERAEGHLS VLHLCALRSL RWQLLSIIVL MAGQQLSGIN AINYYADTIY TSAGVEAAHS QYVTVGSGVV NIVMTITSAV LVERLGRRHL LLAGYGICGS ACLVLTVVLL FQNRVPELSY LGIICVFAYI AGHSIGPSPV PSVVRTEIFL QSSRRAAFMV DGAVHWLTNF IIGFLFPSIQ EAIGAYSFII FAGICLLTAI YIYVVIPETK GKTFVEINRI FAKRNRVKLP EEKEETIDAG PPTASPAKET SF //